199 related articles for article (PubMed ID: 21967987)
1. Response perseveration in stimulant dependence is associated with striatal dysfunction and can be ameliorated by a D(2/3) receptor agonist.
Ersche KD; Roiser JP; Abbott S; Craig KJ; Müller U; Suckling J; Ooi C; Shabbir SS; Clark L; Sahakian BJ; Fineberg NA; Merlo-Pich EV; Robbins TW; Bullmore ET
Biol Psychiatry; 2011 Oct; 70(8):754-762. PubMed ID: 21967987
[TBL] [Abstract][Full Text] [Related]
2. Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence.
Ersche KD; Bullmore ET; Craig KJ; Shabbir SS; Abbott S; Müller U; Ooi C; Suckling J; Barnes A; Sahakian BJ; Merlo-Pich EV; Robbins TW
Arch Gen Psychiatry; 2010 Jun; 67(6):632-44. PubMed ID: 20530013
[TBL] [Abstract][Full Text] [Related]
3. Computational modelling reveals contrasting effects on reinforcement learning and cognitive flexibility in stimulant use disorder and obsessive-compulsive disorder: remediating effects of dopaminergic D2/3 receptor agents.
Kanen JW; Ersche KD; Fineberg NA; Robbins TW; Cardinal RN
Psychopharmacology (Berl); 2019 Aug; 236(8):2337-2358. PubMed ID: 31324936
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic Enhancement of Striatal Response to Reward in Major Depression.
Admon R; Kaiser RH; Dillon DG; Beltzer M; Goer F; Olson DP; Vitaliano G; Pizzagalli DA
Am J Psychiatry; 2017 Apr; 174(4):378-386. PubMed ID: 27771973
[TBL] [Abstract][Full Text] [Related]
5. Impaired Learning From Negative Feedback in Stimulant Use Disorder: Dopaminergic Modulation.
Lim TV; Cardinal RN; Bullmore ET; Robbins TW; Ersche KD
Int J Neuropsychopharmacol; 2021 Nov; 24(11):867-878. PubMed ID: 34197589
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder.
Murray GK; Knolle F; Ersche KD; Craig KJ; Abbott S; Shabbir SS; Fineberg NA; Suckling J; Sahakian BJ; Bullmore ET; Robbins TW
Psychopharmacology (Berl); 2019 Aug; 236(8):2325-2336. PubMed ID: 31201476
[TBL] [Abstract][Full Text] [Related]
7. Brain functional connectivity in stimulant drug dependence and obsessive-compulsive disorder.
Meunier D; Ersche KD; Craig KJ; Fornito A; Merlo-Pich E; Fineberg NA; Shabbir SS; Robbins TW; Bullmore ET
Neuroimage; 2012 Jan; 59(2):1461-8. PubMed ID: 21871569
[TBL] [Abstract][Full Text] [Related]
8. Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment.
Ersche KD; Roiser JP; Lucas M; Domenici E; Robbins TW; Bullmore ET
Psychopharmacology (Berl); 2011 Apr; 214(4):779-89. PubMed ID: 21088959
[TBL] [Abstract][Full Text] [Related]
9. Differential frontal-striatal and paralimbic activity during reversal learning in major depressive disorder and obsessive-compulsive disorder.
Remijnse PL; Nielen MM; van Balkom AJ; Hendriks GJ; Hoogendijk WJ; Uylings HB; Veltman DJ
Psychol Med; 2009 Sep; 39(9):1503-18. PubMed ID: 19171077
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety.
Jimenez-Gomez C; Osentoski A; Woods JH
Behav Pharmacol; 2011 Oct; 22(7):711-3. PubMed ID: 21921841
[TBL] [Abstract][Full Text] [Related]
11. Impaired visuospatial associative memory and attention in obsessive compulsive disorder but no evidence for differential dopaminergic modulation.
Morein-Zamir S; Craig KJ; Ersche KD; Abbott S; Muller U; Fineberg NA; Bullmore ET; Sahakian BJ; Robbins TW
Psychopharmacology (Berl); 2010 Oct; 212(3):357-67. PubMed ID: 20661550
[TBL] [Abstract][Full Text] [Related]
12. Altered activation in fronto-striatal circuits during sequential processing of conflict in unmedicated adults with obsessive-compulsive disorder.
Marsh R; Horga G; Parashar N; Wang Z; Peterson BS; Simpson HB
Biol Psychiatry; 2014 Apr; 75(8):615-22. PubMed ID: 23489416
[TBL] [Abstract][Full Text] [Related]
13. Compulsivity in obsessive-compulsive disorder and addictions.
Figee M; Pattij T; Willuhn I; Luigjes J; van den Brink W; Goudriaan A; Potenza MN; Robbins TW; Denys D
Eur Neuropsychopharmacol; 2016 May; 26(5):856-68. PubMed ID: 26774279
[TBL] [Abstract][Full Text] [Related]
14. Baseline Perfusion Alterations Due to Acute Application of Quetiapine and Pramipexole in Healthy Adults.
Michels L; Scherpiet S; Stämpfli P; Herwig U; Brühl AB
Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27466220
[TBL] [Abstract][Full Text] [Related]
15. Cognitive inflexibility and frontal-cortical activation in pediatric obsessive-compulsive disorder.
Britton JC; Rauch SL; Rosso IM; Killgore WD; Price LM; Ragan J; Chosak A; Hezel DM; Pine DS; Leibenluft E; Pauls DL; Jenike MA; Stewart SE
J Am Acad Child Adolesc Psychiatry; 2010 Sep; 49(9):944-53. PubMed ID: 20732630
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pramipexole and amisulpride on alertness, autonomic and endocrine functions in healthy volunteers.
Samuels ER; Hou RH; Langley RW; Szabadi E; Bradshaw CM
Psychopharmacology (Berl); 2006 Sep; 187(4):498-510. PubMed ID: 16802163
[TBL] [Abstract][Full Text] [Related]
17. Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans.
Ersche KD; Roiser JP; Robbins TW; Sahakian BJ
Psychopharmacology (Berl); 2008 Apr; 197(3):421-31. PubMed ID: 18214445
[TBL] [Abstract][Full Text] [Related]
18. Distinct cortico-striatal connections with subthalamic nucleus underlie facets of compulsivity.
Morris LS; Baek K; Voon V
Cortex; 2017 Mar; 88():143-150. PubMed ID: 28103527
[TBL] [Abstract][Full Text] [Related]
19. Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder.
Remijnse PL; Nielen MM; van Balkom AJ; Cath DC; van Oppen P; Uylings HB; Veltman DJ
Arch Gen Psychiatry; 2006 Nov; 63(11):1225-36. PubMed ID: 17088503
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic challenges in social anxiety disorder: evidence for dopamine D3 desensitisation following successful treatment with serotonergic antidepressants.
Hood SD; Potokar JP; Davies SJ; Hince DA; Morris K; Seddon KM; Nutt DJ; Argyropoulos SV
J Psychopharmacol; 2010 May; 24(5):709-16. PubMed ID: 18838500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
